Abstract 4714: Preclinical evaluation of a novel LSD1 inhibitor SYHA1807 for the treatment of small cell lung cancer
Lingyun Wu(WuXi AppTec (China)), Shuhui Chen(Centre National de la Recherche Scientifique), Lele Zhao(WuXi AppTec (China)), Chi-Chung Chan(WuXi AppTec (China)), Hanyu Yang(Chongqing University), Jian Liu(University of Missouri Health System), Yuanfeng Xia(WuXi AppTec (China)), Jianjun Sun(Capital Medical University)
Cited by 3
Related Papers
Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice
|Nature Medicine|2009|775
Epigenetic Priming of Memory Updating during Reconsolidation to Attenuate Remote Fear Memories
|Cell|2014|364
MRGPRX4 is a bile acid receptor for human cholestatic itch
|eLife|2019|154
Astragalus polysaccharide from Astragalus Melittin ameliorates inflammation via suppressing the activation of TLR-4/NF-κB p65 signal pathway and protects mice from CVB3-induced virus myocarditis
|International Journal of Biological Macromolecules|2018|121